The 2nd National Sero-prevalence Survey of Nepal for COVID-19
National Plan, Policy & Guidelines

The 2nd National Sero-prevalence Survey of Nepal for COVID-19

admin August 29, 2021 1 min read

The Ministry of Health and Population has released a brief press note on key findings of the 2nd National Sero-prevalence […]

The Ministry of Health and Population has released a brief press note on key findings of the 2nd National Sero-prevalence Survey of Nepal for COVID-19.

Key findings

COVID-19 antibody;

  • Detected among 68.6 percent of the total samples (13,161).
  • Among single dose vaccine- 80%
  • Among complete dose (2nd) vaccine- 90%
  • Detected among all regions (himalayan, terai, mountain), urban, rural residents, all age groups.

Shows COVID-19 vaccination is effective.

ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION (1st Sero-prevalence)

SERO
COVID Vaccine COVID-19 COVID-19 Vaccine FAQs COVID19 National Health News National Plan Policy Guidelines Reports Sero-prevalence Survey